Nuvectis Pharma, Inc. (NVCT) Misses Q3 EPS by 3c

Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q3 EPS of ($0.37), $0.03 worse than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c